Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cabenoside D (compound 8), a triterpenoid glycoside derived from the methanol extract of lichen root, exhibits anti-inflammatory activity. It effectively inhibits inflammation and the activation of early Epstein-Barr virus antigen (EBV-EA) induced by 12-O-tetracylacyl hormone-13-acetate (TPA) in mice [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Cabenoside D (compound 8), a triterpenoid glycoside derived from the methanol extract of lichen root, exhibits anti-inflammatory activity. It effectively inhibits inflammation and the activation of early Epstein-Barr virus antigen (EBV-EA) induced by 12-O-tetracylacyl hormone-13-acetate (TPA) in mice [1]. |
Molecular Weight | 636.86 |
Formula | C36H60O9 |
CAS No. | 88901-40-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cabenoside D 88901-40-0 inhibitor inhibit